Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Yoshida, Y. & Yamanaka, S. iPS cells: a source of cardiac regeneration. J. Mol. Cell. Cardiol. 50, 327–332 (2011).
2. Yoshida, Y. & Yamanaka, S. Induced pluripotent stem cells 10 years later: for cardiac applications. Circ. Res. 120, 1958–1968 (2017).
3. Miyagawa, S. Translational research in iPS cell derived cardiomyocyte sheet for the treatment of heart failure. Nihon Rinsho. 74, 667–70 (2016).
4. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131, 861–72 (2007).
5. Sougawa N. et al. Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy. Sci Rep. Published online February 27, 2018,
https://doi.org/10.1038/s41598-018-21923-8
(2018).
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献